Repeatability of [18F]FDG PET/CT total metabolic active tumour volume and total tumour burden in NSCLC patients
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2191-219X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Repeatability of [18F]FDG PET/CT total metabolic active tumour volume and total tumour burden in NSCLC patients ; volume:9 ; number:1 ; day:7 ; month:2 ; year:2019 ; pages:1-12 ; date:12.2019
EJNMMI Research ; 9, Heft 1 (7.2.2019), 1-12, 12.2019
- Creator
-
Kolinger, Guilherme D.
Vállez García, David
Kramer, Gerbrand M.
Frings, Virginie
Smit, Egbert F.
de Langen, Adrianus J.
Dierckx, Rudi A. J. O.
Hoekstra, Otto S.
Boellaard, Ronald
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13550-019-0481-1
- URN
-
urn:nbn:de:101:1-2019031300242078763487
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kolinger, Guilherme D.
- Vállez García, David
- Kramer, Gerbrand M.
- Frings, Virginie
- Smit, Egbert F.
- de Langen, Adrianus J.
- Dierckx, Rudi A. J. O.
- Hoekstra, Otto S.
- Boellaard, Ronald
- SpringerLink (Online service)
Other Objects (12)
Clinically feasible semi-automatic workflows for measuring metabolically active tumour volume in metastatic melanoma
Metabolically active tumour volume segmentation from dynamic [18F]FLT PET studies in non-small cell lung cancer
Mitigating SUV uncertainties using total body PET imaging
Total 18F-dopa PET tumour uptake reflects metabolic endocrine tumour activity in patients with a carcinoid tumour
Assessment of tumour size in PET/CT lung cancer studies: PET- and CT-based methods compared to pathology
Harmonization of nomenclature for molecular imaging metrics of tumour burden: molecular tumour volume (MTV), total lesion activity (TLA) and total lesion fraction (TLF)
Repeatability of two semi-automatic artificial intelligence approaches for tumor segmentation in PET
Accuracy of 3D acquisition mode for myocardial FDG PET studies using a BGO-based scanner
Repeatability of Radiomic Features in Non-Small-Cell Lung Cancer [18F]FDG-PET/CT Studies: Impact of Reconstruction and Delineation
Tumour necrosis as assessed with 18F-FDG PET is a potential prognostic marker in diffuse large B cell lymphoma independent of MYC rearrangements
Interlaboratory Surveys of the Determination of Tumour Markers Scatter and Repeatability of the Results
Off-line motion correction methods for multi-frame PET data
Clinically feasible semi-automatic workflows for measuring metabolically active tumour volume in metastatic melanoma
Metabolically active tumour volume segmentation from dynamic [18F]FLT PET studies in non-small cell lung cancer
Mitigating SUV uncertainties using total body PET imaging
Total 18F-dopa PET tumour uptake reflects metabolic endocrine tumour activity in patients with a carcinoid tumour
Assessment of tumour size in PET/CT lung cancer studies: PET- and CT-based methods compared to pathology
Harmonization of nomenclature for molecular imaging metrics of tumour burden: molecular tumour volume (MTV), total lesion activity (TLA) and total lesion fraction (TLF)
Repeatability of two semi-automatic artificial intelligence approaches for tumor segmentation in PET
Accuracy of 3D acquisition mode for myocardial FDG PET studies using a BGO-based scanner
Repeatability of Radiomic Features in Non-Small-Cell Lung Cancer [18F]FDG-PET/CT Studies: Impact of Reconstruction and Delineation
Tumour necrosis as assessed with 18F-FDG PET is a potential prognostic marker in diffuse large B cell lymphoma independent of MYC rearrangements
Interlaboratory Surveys of the Determination of Tumour Markers Scatter and Repeatability of the Results
Off-line motion correction methods for multi-frame PET data
Clinically feasible semi-automatic workflows for measuring metabolically active tumour volume in metastatic melanoma
Metabolically active tumour volume segmentation from dynamic [18F]FLT PET studies in non-small cell lung cancer
Mitigating SUV uncertainties using total body PET imaging
Total 18F-dopa PET tumour uptake reflects metabolic endocrine tumour activity in patients with a carcinoid tumour
Assessment of tumour size in PET/CT lung cancer studies: PET- and CT-based methods compared to pathology
Harmonization of nomenclature for molecular imaging metrics of tumour burden: molecular tumour volume (MTV), total lesion activity (TLA) and total lesion fraction (TLF)
Repeatability of two semi-automatic artificial intelligence approaches for tumor segmentation in PET
Accuracy of 3D acquisition mode for myocardial FDG PET studies using a BGO-based scanner
Repeatability of Radiomic Features in Non-Small-Cell Lung Cancer [18F]FDG-PET/CT Studies: Impact of Reconstruction and Delineation
Tumour necrosis as assessed with 18F-FDG PET is a potential prognostic marker in diffuse large B cell lymphoma independent of MYC rearrangements
Interlaboratory Surveys of the Determination of Tumour Markers Scatter and Repeatability of the Results